• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Sr MD Gl Hd Commodities Mkts Sammann Derek disposed of 2,175 units of Common Stock Class A, acquired 2,175 units of Common Stock Class A and sold $1,304,847 worth of Common Stock Class A (4,650 units at $280.61), decreasing direct ownership by 19% to 9,417 units (SEC Form 4)

    5/7/25 6:16:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sammann Derek

    (Last) (First) (Middle)
    20 S. WACKER DRIVE

    (Street)
    CHICAGO IL 60606

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CME GROUP INC. [ CME ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Sr MD Gl Hd Commodities Mkts
    3. Date of Earliest Transaction (Month/Day/Year)
    03/18/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock Class A 03/18/2025 J 2,175 D $0 9,417(1) D
    Common Stock Class A 03/18/2025 J 2,175 A $0 16,789(1) I by Trust
    Common Stock Class A 05/05/2025 S 2,175 D $280.6264 14,614 I by Trust
    Common Stock Class A 05/05/2025 S 2,475 D $280.6 8,336 I by Spouse
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Ownership has been updated to reflect the transfer of CME Group Class A common stock on October 31, 2024 to reporting person's revocable living trust.
    Remarks:
    By: Jenelle Chalmers For: Derek Louis Sammann 05/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    6/21/2024$206.00 → $187.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CME Group upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

      4/8/25 9:08:11 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Raymond James with a new price target

      Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

      3/10/25 7:18:35 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group downgraded by Citigroup with a new price target

      Citigroup downgraded CME Group from Buy to Neutral and set a new price target of $250.00 from $255.00 previously

      1/6/25 7:45:08 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance